Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

PURPOSE: We and others have reported that adding adefovir dipivoxil (adefovir) to lamivudine results in virological and biochemical improvement in cases of lamivudine resistance. The current study assessed the efficacy and safety of combined therapy after 104 weeks of combined treatment and analyzed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Perrillo, Robert P., Hann, Hie-Won, Schiff, Eugene, Mutimer, David, Willems, Bernard, Leung, Nancy, Lee, William M., Dixon, Susan, Woessner, Mary, Brosgart, Carol L., Condreay, Lynn D., Gardner, Stephen D.
Format: Artigo
Idioma:Inglês
Publicat: Springer-Verlag 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3090563/
https://ncbi.nlm.nih.gov/pubmed/21484148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-010-9228-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars